NOS2 and Alzheimer disease: To investigate whether azole drugs can be useful for AD through the inhibition of iNOS expression and the consequential neuroinflammation, we administered MCZ, an azole drug, and evaluated the anti-AD effect and its active mechanism based on bioinformatics analysis (Supplementary Fig. 1).